Search

Search Constraints

You searched for: Author/Creator Faggiani, Roberto

Search Results

1. Long-term real-life efficacy and safety of infliximab and adalimumab in the treatment of inflammatory bowel diseases outpatients. Issue 5 (19th March 2021)

2. Effectiveness of ustekinumab in patients with refractory Crohn's disease: a multicentre real-life study in Italy. (February 2022)

4. Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study. Issue 4 (1st August 2016)

5. Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers. Issue 34 (August 2018)

6. Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study. Issue 4 (August 2016)

7. Real-world efficacy and safety of vedolizumab in managing ulcerative colitis versus Crohn's disease: results from an Italian multicenter study. (4th March 2023)